Sex and type 2 diabetes: Obesity-independent effects on left ventricular substrate metabolism and relaxation in humans

Obesity

Volumn 20, Issue 4, 2012, Pages 802-810

  Peterson, Linda R ^a   Saeed, Ibrahim M ^a   McGill, Janet B ^a   Herrero, Pilar ^b   Schechtman, Kenneth B ^a   Gunawardena, Ratnasiri ^a   Recklein, Carol L ^a   Coggan, Andrew R ^b   Demoss, Amanda J ^b   Dence, Carmen S ^b   Gropler, Robert J ^b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACARBOSE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FATTY ACID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; METFORMIN; SULFONYLUREA;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC PATIENT; ECHOCARDIOGRAPHY; ESTERIFICATION; FATTY ACID BLOOD LEVEL; FATTY ACID METABOLISM; FATTY ACID OXIDATION; FEMALE; GLUCOSE TRANSPORT; GLUCOSE UTILIZATION; HEART FUNCTION; HEART LEFT VENTRICLE RELAXATION; HEART LEFT VENTRICLE SUBTRATE METABOLISM; HEART MUSCLE; HEART MUSCLE BLOOD FLOW; HEART MUSCLE METABOLISM; HUMAN; INSULIN BLOOD LEVEL; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OXYGEN CONSUMPTION; POSITRON EMISSION TOMOGRAPHY; PREDICTION; SEX DIFFERENCE;

ADULT; BLOOD GLUCOSE; BODY MASS INDEX; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; ECHOCARDIOGRAPHY; FATTY ACIDS; FEMALE; HUMANS; INSULIN RESISTANCE; MALE; MIDDLE AGED; MUSCLE RELAXATION; MYOCARDIUM; OBESITY; OXYGEN CONSUMPTION; POSITRON-EMISSION TOMOGRAPHY; SEX FACTORS; VENTRICULAR DYSFUNCTION, LEFT;

ANIMALIA;

EID: 84859217303     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2011.208     Document Type: Article

References (40)

1. Grundy SM, Cleeman JI, Daniels SR et al.; American Heart Association; National Heart, Lung, and Blood Institue. Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Executive summary. Cardiol Rev 2005;13:322-327.
2. Harris MI, Flegal KM, Cowie CC et al. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988-1994. Diabetes Care 1998;21:518-524. (Pubitemid 28172927)
3. Mokdad AH, Ford ES, Bowman BA et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 2003;289:76-79. (Pubitemid 36026281)
4. Kannel WB, McGee DL. Diabetes and cardiovascular disease. The Framingham study. JAMA 1979;241:2035-2038. (Pubitemid 9228506)
5. Kannel WB, Hjortland M, Castelli WP. Role of diabetes in congestive heart failure: the Framingham study. Am J Cardiol 1974;34:29-34.
6. Ahmed A, Aban IB, Vaccarino V et al. A propensity-matched study of the effect of diabetes on the natural history of heart failure: variations by sex and age. Heart 2007;93:1584-1590. (Pubitemid 350205556)
7. Aasum E, Hafstad AD, Severson DL, Larsen TS. Age-dependent changes in metabolism, contractile function, and ischemic sensitivity in hearts from db/db mice. Diabetes 2003;52:434-441. (Pubitemid 36173200)
8. Zhou YT, Grayburn P, Karim A et al. Lipotoxic heart disease in obese rats: implications for human obesity. Proc Natl Acad Sci USA 2000;97: 1784-1789. (Pubitemid 30118520)
9. Listenberger LL, Ory DS, Schaffer JE. Palmitate-induced apoptosis can occur through a ceramide-independent pathway. J Biol Chem 2001;276:14890-14895.
10. Ohtake T, Yokoyama I, Watanabe T et al. Myocardial glucose metabolism in noninsulin-dependent diabetes mellitus patients evaluated by FDG-PET. J Nucl Med 1995;36:456-463.
11. van der Meer RW, Rijzewijk LJ, de Jong HW et al. Pioglitazone improves cardiac function and alters myocardial substrate metabolism without affecting cardiac triglyceride accumulation and high-energy phosphate metabolism in patients with well-controlled type 2 diabetes mellitus. Circulation 2009;119:2069-2077.
12. Rijzewijk LJ, van der Meer RW, Lamb HJ et al. Altered myocardial substrate metabolism and decreased diastolic function in nonischemic human diabetic cardiomyopathy: studies with cardiac positron emission tomography and magnetic resonance imaging. J Am Coll Cardiol 2009;54:1524-1532.
13. Peterson LR, Soto PF, Herrero P et al. Sex differences in myocardial oxygen and glucose metabolism. J Nucl Cardiol 2007;14:573-581. (Pubitemid 47163554)
14. Peterson LR, Soto PF, Herrero P et al. Impact of gender on the myocardial metabolic response to obesity. JACC Cardiovasc Imaging 2008;1: 424-433. (Pubitemid 351998685)
15. Bergmann SR, Herrero P, Markham J, Weinheimer CJ, Walsh MN. Noninvasive quantitation of myocardial blood flow in human subjects with oxygen-15-labeled water and positron emission tomography. J Am Coll Cardiol 1989;14:639-652. (Pubitemid 19229339)
16. Buck A, Wolpers HG, Hutchins GD et al. Effect of carbon-11-acetate recirculation on estimates of myocardial oxygen consumption by PET. J Nucl Med 1991;32:1950-1957.
17. Herrero P, Kisrieva-Ware Z, Dence CS et al. PET measurements of myocardial glucose metabolism with 1-11C-glucose and kinetic modeling. J Nucl Med 2007;48:955-964. (Pubitemid 46909924)
18. Bergmann SR, Weinheimer CJ, Markham J, Herrero P. Quantitation of myocardial fatty acid metabolism using PET. J Nucl Med 1996;37: 1723-1730. (Pubitemid 26337187)
19. Matthews DR, Hosker JP, Rudenski AS et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-419. (Pubitemid 15018832)
20. Peterson LR, Waggoner AD, Schechtman KB et al. Alterations in left ventricular structure and function in young healthy obese women: assessment by echocardiography and tissue Doppler imaging. J Am Coll Cardiol 2004;43:1399-1404. (Pubitemid 38496345)
21. Solomon SD, Janardhanan R, Verma A et al.; Valsartan In Diastolic Dysfunction (VALIDD) Investigators. Effect of angiotensin receptor blockade and antihypertensive drugs on diastolic function in patients with hypertension and diastolic dysfunction: A randomised trial. Lancet 2007;369:2079-2087. (Pubitemid 46935945)
22. Gardin JM, Siscovick D, Anton-Culver H et al. Sex, age, and disease affect echocardiographic left ventricular mass and systolic function in the free-living elderly. The Cardiovascular Health Study. Circulation 1995;91:1739-1748.
23. Ungar I, Gilbert M, Siegel A, Blain JM, Bing RJ. Studies on myocardial metabolism. IV. Myocardial metabolism in diabetes. Am J Med 1955;18:385-396.
24. Alavaikko M, Elfving R, Hirvonen J, Jvi J. Triglycerides, cholesterol, and phospholipids in normal heart papillary muscle and in patients suffering from diabetes, cholelithiasis, hypertension, and coronary atheroma. J Clin Pathol 1973;26:285-293.
25. Rijzewijk LJ, van der Meer RW, Smit JW et al. Myocardial steatosis is an independent predictor of diastolic dysfunction in type 2 diabetes mellitus. J Am Coll Cardiol 2008;52:1793-1799.
26. Mittendorfer B, Magkos F, Fabbrini E, Mohammed BS, Klein S. Relationship between body fat mass and free fatty acid kinetics in men and women. Obesity (Silver Spring) 2009;17:1872-1877.
27. Mittendorfer B, Horowitz JF, Klein S. Gender differences in lipid and glucose kinetics during short-term fasting. Am J Physiol Endocrinol Metab 2001;281:E1333-E1339.
28. Matute ML, Kalkhoff RK. Sex steroid influence on hepatic gluconeogenesis and glucogen formation. Endocrinology 1973;92:762-768.
29. Kendrick ZV, Ellis GS. Effect of estradiol on tissue glycogen metabolism and lipid availability in exercised male rats. J Appl Physiol 1991;71:1694-1699.
30. Herrero P, Soto PF, Dence CS et al. Impact of hormone replacement on myocardial fatty acid metabolism: potential role of estrogen. J Nucl Cardiol 2005;12:574-581. (Pubitemid 41364060)
31. Boudina S, Sena S, Theobald H et al. Mitochondrial energetics in the heart in obesity-related diabetes: direct evidence for increased uncoupled respiration and activation of uncoupling proteins. Diabetes 2007;56:2457-2466. (Pubitemid 47523253)
32. Vik-Mo H, MJ OD. Influence of free fatty acids on myocardial oxygen consumption and ischemic injury. Am J Cardiol 1981;48:361-365.
33. Peterson LR, Herrero P, McGill J et al. Fatty acids and insulin modulate myocardial substrate metabolism in humans with type 1 diabetes. Diabetes 2008;57:32-40.
34. Cook SA, Varela-Carver A, Mongillo M et al. Abnormal myocardial insulin signalling in type 2 diabetes and left-ventricular dysfunction. Eur Heart J 2010;31:100-111.
35. Utriainen T, Takala T, Luotolahti M et al. Insulin resistance characterizes glucose uptake in skeletal muscle but not in the heart in NIDDM. Diabetologia 1998;41:555-559. (Pubitemid 28206826)
36. Scheuermann-Freestone M, Madsen PL, Manners D et al. Abnormal cardiac and skeletal muscle energy metabolism in patients with type 2 diabetes. Circulation 2003;107:3040-3046. (Pubitemid 36758977)
37. Boyer JK, Thanigaraj S, Schechtman KB, Pez JE. Prevalence of ventricular diastolic dysfunction in asymptomatic, normotensive patients with diabetes mellitus. Am J Cardiol 2004;93:870-875. (Pubitemid 38429599)
38. Rutter MK, Parise H, Benjamin EJ et al. Impact of glucose intolerance and insulin resistance on cardiac structure and function: sex-related differences in the Framingham Heart Study. Circulation 2003;107:448-454. (Pubitemid 36158048)
39. Okura H, Takada Y, Yamabe A et al. Age-and gender-specific changes in the left ventricular relaxation: a Doppler echocardiographic study in healthy individuals. Circ Cardiovasc Imaging 2009;2:41-46.
40. Regitz-Zagrosek V, Brokat S, Tschope C. Role of gender in heart failure with normal left ventricular ejection fraction. Prog Cardiovasc Dis 2007;49: 241-251. (Pubitemid 44932176)